Does RUXOLITINIB Cause Increased appetite? 287 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 287 reports of Increased appetite have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.4% of all adverse event reports for RUXOLITINIB.
287
Reports of Increased appetite with RUXOLITINIB
0.4%
of all RUXOLITINIB reports
18
Deaths
42
Hospitalizations
How Dangerous Is Increased appetite From RUXOLITINIB?
Of the 287 reports, 18 (6.3%) resulted in death, 42 (14.6%) required hospitalization, and 4 (1.4%) were considered life-threatening.
Is Increased appetite Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 287 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Increased appetite?
SEMAGLUTIDE (980)
RISPERIDONE (808)
TIRZEPATIDE (640)
OLANZAPINE (556)
ARIPIPRAZOLE (465)
QUETIAPINE (389)
PREDNISONE (265)
PREGABALIN (265)
GABAPENTIN (253)
CLOZAPINE (230)
Which RUXOLITINIB Alternatives Have Lower Increased appetite Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE